Roche’s HER2-Positive Breast Cancer Treatments: A Pillar of Modern Oncology
Roche’s HER2-Positive Breast Cancer Treatment Franchise Roche has established itself as a leading force in the fight against HER2-positive breast cancer, a particularly aggressive form of the disease characterized by overexpression of the HER2 protein on cancer cells. The company’s HER2-positive breast cancer treatment franchise represents a cornerstone of their oncology portfolio, offering innovative therapies…